This included 3.1 million CT scans in 2.6 million children and 89.9 million CT scans ... 21,400), colon cancer (n=8400), leukemia (n=7400), bladder cancer (n=6900), and stomach cancer (n=6800).

This randomised, open-label phase 3 clinical trial compared subcutaneous and IV nivolumab in patients with previously treated advanced or metastatic clear cell renal cell carcinoma. The results ...

May is Bladder Cancer Awareness Month and at Frontiers in Oncology, we are dedicated to spotlighting the groundbreaking discoveries transforming the ...

We are investigating the mechanisms by which cancer mutations deregulate the normal processes of cellular function and growth ...

The median progression-free survival per blinded independent review was 9.6 months in the penpulimab arm and 7.0 months in the placebo arm. Adding penpulimab to chemotherapy can improve ...

(HealthDay News) — The new commissioner of the US Food and Drug Administration (FDA), Dr Marty Makary, has shared details about his first weeks on the job, his vision for the future, and why he ...

(UroToday.com) The 2025 AUA annual meeting featured the IBCG Bladder Cancer Forum evaluating common problems ... high grade T1 or high risk Ta urothelial carcinoma, a clinician should administer a six ...

Non-muscle invasive bladder cancer (NMIBC) has a long history of intravesical ... Medical Oncology, Translational Research, Novel molecular targeted agents, Biomarkers, Imaging (PET scans, MRI), Bone ...